New in vitro results show Telomir-1 adds KDM5 family inhibition to its previously reported KDM2/KDM6 and DNA methylation activity, potentially representing a novel frontier in epigenetic therapy where no existing candidates have shown comparable breadth.

The Company plans to use the proceeds to accelerate the development of Teverelix, a next generation GnRH Antagonist, as a first in class market product for Acute Urinary Retention (AURr) and high CV risk Prostate Cancer collecting representing ~ $6 billion in potential market opportunity

Missing the signs of spondyloarthritis delays diagnosis and treatment.

New Capabilities Place Peer-reviewed Literature Review Evidence at the Fingertips of Research and Commercial Teams to Align Decision-making and Improve Productivity

Leadership change positions NCQA for the next generation of quality improvement.

Keensight Capital ("Keensight"), one of the leading private equity managers dedicated to pan-European Growth Buyout ^[1] investments, today announced it has agreed to acquire a majority stake in Isto Biologics ("Isto") from Thompson Street Capital Partners ("TSCP"). TSCP will retain a minority stake, alongside Isto Biologics' management team.

Industry-recognized expert SciBite, and Pistoia Alliance Board Member, joins Rancho to advance structured data solutions for life sciences innovation

Icotrokinra demonstrated superior skin clearance at Weeks 16 and 24 compared to deucravacitinib and similar adverse event rates to placebo in Phase 3 ICONIC-ADVANCE studies

Icotrokinra also showed sustained skin clearance and favorable safety profile in both adults and adolescents at Week 52 in Phase 3 ICONIC-LEAD study

Preclinical proof-of-concept data on PN-881, a first-in-class oral peptide targeting the IL-17 pathway, and part of Protagonist's fully owned development pipeline, including the highly potent and selective binding of IL-17A and IL-17F

- Abstract highlights additional primary and secondary data from Phase 3 STAR-1 clinical study of XYNGARI™ for the treatment of moderate-to-severe acne -

PowerBite Reviews 2025: Full Ingredient List, Side Effects, Pricing, Complaints, and Legit Check

Ahead of MEDITECH LIVE 2025 this week, Black Book releases survey findings from 128 hospital clients, conducted prior to the event.

Black Book survey: IT modernization is the lever to keep home health nurses and protect access as Medicare rate changes loom

Mass General Brigham expands the reach of its Medicare-approved Benson-Henry Institute Intensive Cardiac Rehabilitation program through virtual and center-based partnerships

11 Health Plans Earn Top 5-Star Rating

The Best FTM Top Surgeon in the US is Dr. Javad Sajan at Allure Esthetic

Sustained acoustic medicine helps athletes bridge that critical gap between recovery and performance by providing an advanced, non-invasive therapy proven to accelerate healing and reduce pain

Part of New Contract Manufacturing Agreement with SupraNaturals to Secure Additional Production Capacity

• SupraNaturals is a leading private label manufacturer in the health and wellness industry

• BUZZ BOMB™ pre-workout:

  • 50mg caffeine for energy and focus.

  • Boosts performance potential.

  • Stick packs:

    • Convenient, no water needed.

    • Precise caffeine dose

Global Market Insights: Pre-Workout Supplements

• Market Size in 2024: $19.6 billion

• Projected Market Size by 2030: $27.9 billion

• Compound Annual Growth Rate (CAGR): 5.9%

No dose-limiting toxicities or cytokine release syndrome observed in RAINIER to date; mipletamig shows consistently favorable safety and tolerability

Trial progressing efficiently, Cohort 4 open for enrollment

MIRA advances Ketamir-2 in the clinic for neuropathic pain while broadening development into neuropsychiatric disorders such as PTSD

The U.S. marijuana dispensary market is projected to generate over $31.8 billion annually by 2025, creating multi-million-dollar opportunities for CBDL through dispensary partnerships and large-scale beverage distribution in sports stadiums nationwide.

Leading life science executives, government officials, academic leaders, and investors gather for two day off-the-record networking and discussion forum

Aprecia will use Apprentice.io's AI-powered platform to scale its innovative technology for drug delivery solutions

Preliminary analysis showed the 2025-2026 formula of Spikevax generated greater than an 8-fold increase in LP.8.1-neutralizing antibodies across age groups

Clinical findings reinforce preclinical data supporting recent FDA approval of 2025-2026 formula of Spikevax

-Study to Evaluate Usability and Extended Wear for Next-Generation Tubeless Patch Pump

Black Book Insights' global survey of 404 executives across 40 countries forecasts USD 65 billion in annual non-U.S. payer IT spend by 2027 - rivaling U.S. health insurer technology budgets.

Nationwide initiative pairs eligible college athletes with trusted LASIK surgeons and a compliant, content‑first partnership model

MMJ International Holdings Is Betting on Medicine, Not Marijuana

Is Pharmaceutical Grade Cannabis Aiming for the Next Blockbuster?

Slim Portable Readers With Durable Polycarbonate Lenses, Full 2025 Pricing and Warranty Guide, and Real User Reviews

Strategic leadership changes align with Canyon Labs' vision to scale services while strengthening its commitment to customer partnerships.

SKNY transaction strengthens MIRA pipeline with SKNY-1, a differentiated oral candidate that has demonstrated up to 30% weight loss and nicotine craving reversal in preclinical studies.

PharmaNest Inc. announced today a multi-institutional research collaboration with Virginia Commonwealth University (VCU) and the National Institutes of Health (NIH) to confirm the prognostic performance of artificial intelligence (AI) powered digital pathology biomarkers in metabolic dysfunction-associated steatotic liver disease (MASLD) in a retrospective cohort of 1,765 patients with MASH (NASH CRN DB2 Cohort)

Honest 2025 NovaMedic Pro Review: Real Customer Complaints, FDA-Cleared Accuracy, Pricing, and Refund Details

Viral TikTok Pink Salt Trick vs Science-Backed Lipovive: 2025 Expert Comparison, Real User Reviews, Safety Guide & Pricing Analysis

- Use of MODD1 on clinicians with Type 1 diabetes

Black Book Research to Recognize Vendor Excellence Across Patient Safety IT Categories

With high-value assets including a LeBron James 2016 NBA Finals game worn jersey and rare Tom Brady 1/1 card, Infinite Auctions bolsters MDCE's balance sheet to accelerate development of its AI health platform.

One Billion People Living With Mental Health Conditions

This release is being retransmitted for extra exposure to downstream sites.

Strategic collaboration will integrate Sheba's real-world data with Imagene AI's Cross Modality Intelligence Engine to enable multimodal research, predictive models, and faster translation to care

"Partnering with an innovative leader like Imagene AI strengthens our mission to transform Sheba into an AI-driven hospital and a global model of healthcare innovation"

Icotrokinra is a first-in-class investigational targeted oral peptide that selectively blocks the IL-23 receptor ¹

Filing based on four Phase 3 studies that met all primary and co-primary endpoints. This unprecedented data package includes head-to-head superiority comparisons versus deucravacitinib, adolescent data, and evaluation of difficult to treat skin sites^2,3,4,5,6

Submission underscores that icotrokinra has the potential to offer moderate-to-severe plaque psoriasis patients the combination of complete skin clearance and a favourable safety profile, relative to comparators, with the simplicity of a once-daily tablet. ^2,3,4,5,6

An evening of candlelight, music, and advocacy at the Mayfair House Hotel & Garden to support early breast cancer detection and awareness worldwide